The Impact of COVID-19 on Maternal Mental Health during Pregnancy: A Comparison between Canada and China within the CONCEPTION Cohort.

Autor: Pagès N; Research Center CHU Ste-Justine, Montreal, QC H3T 1C5, Canada.; Faculty of Medicine, Université Claude Bernard Lyon 1, 69003 Lyon, France., Gorgui J; Research Center CHU Ste-Justine, Montreal, QC H3T 1C5, Canada.; Faculty of Pharmacy, University of Montreal, Montreal, QC H3T 1J4, Canada., Wang C; College of Public Health, Zhengzhou University, Zhengzhou 450001, China., Wang X; College of Public Health, Zhengzhou University, Zhengzhou 450001, China., Zhao JP; Research Center CHU Ste-Justine, Montreal, QC H3T 1C5, Canada., Tchuente V; Research Center CHU Ste-Justine, Montreal, QC H3T 1C5, Canada., Lacasse A; Health Sciences Department, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, QC J9X 5E4, Canada., Côté S; Research Center CHU Ste-Justine, Montreal, QC H3T 1C5, Canada.; Faculty of Medicine, School of Public Health, University of Montreal, Montreal, QC H3T 1J4, Canada., King S; Faculty of Medicine, McGill University, Montreal, QC H3G 2M1, Canada., Muanda F; Department of Epidemiology & Biostatistics, Western University, London, ON N6A 5W9, Canada.; ICES Western, Western University, London, ON N6A 5W9, Canada., Mufike Y; Department of Family Medicine, Protestant University in Congo, Kinshasa II, Kinshasa P.O. Box 4745, Democratic Republic of the Congo., Boucoiran I; Research Center CHU Ste-Justine, Montreal, QC H3T 1C5, Canada.; Department of Obstetrics and Gynecology, School of Public Health, University of Montreal, Montreal, QC H3N 1X9, Canada., Nuyt AM; Research Center CHU Ste-Justine, Montreal, QC H3T 1C5, Canada.; Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC H3T 1C5, Canada., Quach C; Research Center CHU Ste-Justine, Montreal, QC H3T 1C5, Canada.; Department of Microbiology, Infectious Diseases and Immunology, University of Montreal, Montreal, QC H3T 1J4, Canada., Ferreira E; Faculty of Pharmacy, University of Montreal, Montreal, QC H3T 1J4, Canada.; Pharmacy Department, CHU Sainte-Justine, Montreal, QC H3T 1C5, Canada., Kaul P; Department of Medicine, 4-120 Katz Group Centre for Pharmacy and Health Research, University of Alberta, Edmonton, AL T6G 2R7, Canada., Winquist B; Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada., O'Donnell KJ; Yale Child Study Center, Department of OB/GYN and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06510, USA.; Douglas Research Center, Department of Psychiatry, McGill University, Montreal, QC H4H 1R3, Canada., Eltonsy S; Rady Faculty of Health Sciences, College of Pharmacy, University of Manitoba, Winnipeg, MB R3E 0W2, Canada., Chateau D; Manitoba Center for Health Policy, Winnipeg, MB R3E 3P5, Canada., Hanley G; Department of Obstetrics & Gynaecology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada., Oberlander T; Department of Pediatrics, School of Population and Public Health, University of BC, Vancouver, BC V6T 1Z4, Canada., Kassai B; Faculty of Medicine, Université Claude Bernard Lyon 1, 69003 Lyon, France.; Department of Clinical Epidemiology, UMR 5558 CNRS, Clinical Investigation Centre, Inserm-Hospices Civils de Lyon, Claude Bernard University Lyon 1, 69003 Lyon, France., Mainbourg S; Research Center CHU Ste-Justine, Montreal, QC H3T 1C5, Canada.; Department of Clinical Epidemiology, UMR 5558 CNRS, Clinical Investigation Centre, Inserm-Hospices Civils de Lyon, Claude Bernard University Lyon 1, 69003 Lyon, France., Bernatsky S; Divisions of Clinical Epidemiology and Rheumatology, McGill University Health Centre, Montreal, QC H3A 0G4, Canada., Vinet É; Divisions of Clinical Epidemiology and Rheumatology, McGill University Health Centre, Montreal, QC H3A 0G4, Canada., Brodeur-Doucet A; Dispensaire Diététique de Montréal/Montreal Diet Dispensary, Montreal, QC H3H 1J3, Canada., Demers J; Dispensaire Diététique de Montréal/Montreal Diet Dispensary, Montreal, QC H3H 1J3, Canada., Richebé P; Department of Anesthesiology and Pain Medicine, CIUSSS de l'Est de l'Ile de Montreal, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, QC H1T 2M4, Canada., Zaphiratos V; Department of Anesthesiology and Pain Medicine, CIUSSS de l'Est de l'Ile de Montreal, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, QC H1T 2M4, Canada., Bérard A; Research Center CHU Ste-Justine, Montreal, QC H3T 1C5, Canada.; Faculty of Medicine, Université Claude Bernard Lyon 1, 69003 Lyon, France.; Faculty of Pharmacy, University of Montreal, Montreal, QC H3T 1J4, Canada.
Jazyk: angličtina
Zdroj: International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Sep 28; Vol. 19 (19). Date of Electronic Publication: 2022 Sep 28.
DOI: 10.3390/ijerph191912386
Abstrakt: The effect of the COVID-19 pandemic on maternal mental health has been described in Canada and China but no study has compared the two countries using the same standardized and validated instruments. In this study, we aimed to evaluate and compare the impact of COVID-19 public health policies on maternal mental health between Canada and China, as we hypothesize that geographical factors and different COVID-19 policies are likely to influence maternal mental health. Pregnant persons >18 years old were recruited in Canada and China using a web-based strategy. All participants recruited between 26 June 2020 and 16 February 2021 were analyzed. Self-reported data included sociodemographic variables, COVID-19 experience and maternal mental health assessments (Edinburgh Perinatal Depression Scale (EPDS), Generalized Anxiety Disorders (GAD-7) scale, stress and satisfaction with life). Analyses were stratified by recruitment cohort, namely: Canada 1 (26 June 2020-10 October 2020), Canada 2 and China (11 October 2020-16 February 2021). Overall, 2423 participants were recruited, with 1804 participants within Canada 1, 135 within Canada 2 and 484 in China. The mean EDPS scores were 8.1 (SD, 5.1) in Canada 1, 8.1 (SD, 5.2) in Canada 2 and 7.7 (SD, 4.9) in China ( p -value Canada 2/China: p = 0.005). The mean GAD-7 scores were 2.6 (SD, 2.9) in China, 4.3 (SD, 3.8) in Canada 1 ( p < 0.001) and 5.8 (SD, 5.2) in Canada 2 ( p < 0.001). When adjusting for stress and anxiety, being part of the Chinese cohort significantly increased the chances of having maternal depression by over threefold (adjusted OR 3.20, 95%CI 1.77-5.78). Canadian and Chinese participants reported depressive scores nearly double those of other crises and non-pandemic periods. Lockdowns and reopening periods have an important impact on levels of depression and anxiety among pregnant persons.
Databáze: MEDLINE